Evolutionary Genomics Inc (FNAM) Return on Assets ROA from the fourth quarter of 2022 to fourth quarter of 2021 and for the year 2022, Average High and Low, Fundamental Ratios from Dec 31 2022 to Dec 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Evolutionary Genomics Inc   (FNAM)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Evolutionary Genomics Inc 's ROA from the fourth quarter of 2022 to the fourth quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Evolutionary Genomics Inc 's ROA in the fourth quarter of 2022?
Evolutionary Genomics Inc recorded a cumulative net loss of $-2 million during 12 months ending in the fourth quarter of 2022, resulting in a negative return on assets (ROA) of -66.07%.

However, within the Healthcare sector 957 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2022 from 5113 to 5681.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Total Assets Change -17.07 % -33.53 % -4.56 % -2.94 % -26.56 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -2 -2 -3 -3 -3
Return On Assets (TTM) -66.07 % -74.31 % -82.02 % -81.8 % -80.85 %
FNAM's Total Ranking # 5681 # 5113 # 5321 # 5257 # 5597
Total Assets (TTM) in million 2 3 3 4 3
Seq. Total Assets Change -9.51 % -13.02 % -11.84 % 19.54 % -27.47 %
Seq. Net Income Change - - - - -

FNAM's 5 Years Annual ROA >> Back to FNAM Management Effectiveness >> Compare FNAM ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 47
Sector # 958
Overall # 5506

Return On Assets Statistics
High Average Low
38935.64 %
2937.46 %
-7320 %
(Sep 30 2014)   (Jun 30 2012)





Financial Statements
Evolutionary Genomics Inc 's Assets $ 2 million FNAM's Balance sheet
Evolutionary Genomics Inc 's Income $ 0 million Quarterly FNAM's Income Statement
FNAM's Income by Division See FNAM's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018
Y / Y Total Assets Change -17.07 % -26.56 % -5.89 % -3.33 % -18.72 %
Total Assets in million 2 3 4 4 4
Y / Y Net Income Change - - - - -
Net Income in million -2 -3 -2 -1 -1
Annual Return On Assets -79.57 % -95.29 % -42.88 % -18.69 % -25.03 %

FNAM's 5 Years Annual ROA >> Back to FNAM Management Effectiveness >> Compare FNAM ROA to its Competitors



More Return On Assets Ratios
FNAM's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
FNAM's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for FNAM's Competitors
Subscribers only: Roa for Evolutionary Genomics Inc 's Suppliers
Subscribers only: Return On Assets for FNAM's Customers

You may also want to know
FNAM's Roi FNAM's Inventory Turnover Ratio FNAM's Growth Rates FNAM's Dividend Comparisons
FNAM's Profitability Ratios FNAM's Asset Turnover Ratio FNAM's Dividend Growth
FNAM's Roe FNAM's Valuation Ratios FNAM's Financial Strength Ratios FNAM's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2022, within Healthcare Sector ROA

Date modified: 2026-08-29T07:14:09+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.